Linden Rhoads
General Manager & Board Member · The W Fund
Linden Rhoads invests exclusively in early-stage technology and life science spin-outs from Washington State research institutions, primarily targeting check sizes of 50,000 to $500,000 per company [3][6]. Her distinctive thesis focuses on commercializing university discoveries, with a portfolio including notable companies like Vicis (medical devices), Mobisante (ultrasound imaging), and C-SATS…
- Stages: Early Stage VC, Later Stage VC, Seed Round
- Focus: Pharmaceuticals and Biotechnology, Software
- Location: Seattle, WA
Website
Browse all investors · Browse founders